FMCSX
Price
$44.69
Change
+$0.01 (+0.02%)
Updated
Oct 17 closing price
Net Assets
7.72B
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

FMCSX vs VIMAX

Header iconFMCSX vs VIMAX Comparison
Open Charts FMCSX vs VIMAXBanner chart's image
Fidelity Mid-Cap Stock
Price$44.69
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets7.72B
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
FMCSX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
FMCSX vs. VIMAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMCSX is a Hold and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. FMCSX (7.72B). VIMAX pays higher dividends than FMCSX: VIMAX (1.48) vs FMCSX (0.56). FMCSX was incepted earlier than VIMAX: FMCSX (32 years) vs VIMAX (24 years). FMCSX (0.67) is less costly to investors than VIMAX (0.05). FMCSX is a more actively managed with annual turnover of: 51.00 vs. VIMAX (16.00). FMCSX has a lower initial minimum investment than VIMAX: FMCSX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. FMCSX (0.79). VIMAX return over 5 years is better than : 57.32 vs. FMCSX (37.09).
FMCSXVIMAXFMCSX / VIMAX
Total Expense Ratio0.670.051,340%
Annual Report Gross Expense Ratio0.670.051,340%
Fund Existence32 years24 years-
Gain YTD5.5119.70757%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.72B201B4%
Annual Yield % from dividends0.561.4838%
Returns for 1 year0.797.5810%
Returns for 3 years26.5149.7053%
Returns for 5 years37.0957.3265%
Returns for 10 years31.42140.9322%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ABVC2.92N/A
N/A
ABVC BioPharma
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals